JO2334B1 - Drospirenone for hormone replacement therapy - Google Patents

Drospirenone for hormone replacement therapy

Info

Publication number
JO2334B1
JO2334B1 JO200110A JOP20010010A JO2334B1 JO 2334 B1 JO2334 B1 JO 2334B1 JO 200110 A JO200110 A JO 200110A JO P20010010 A JOP20010010 A JO P20010010A JO 2334 B1 JO2334 B1 JO 2334B1
Authority
JO
Jordan
Prior art keywords
estrogen
beta
menopausal
drospirenone
hormone replacement
Prior art date
Application number
JO200110A
Other languages
Arabic (ar)
English (en)
Inventor
جانج هيل وولف
ليب رودلف
شيرمان رولف
هيلمان جيرجين
Original Assignee
باير شيرنغ فارما اكتنجيسيلشافت
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by باير شيرنغ فارما اكتنجيسيلشافت filed Critical باير شيرنغ فارما اكتنجيسيلشافت
Application granted granted Critical
Publication of JO2334B1 publication Critical patent/JO2334B1/en

Links

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
JO200110A 2000-01-18 2001-01-11 Drospirenone for hormone replacement therapy JO2334B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP00200183 2000-01-18

Publications (1)

Publication Number Publication Date
JO2334B1 true JO2334B1 (en) 2006-06-28

Family

ID=38170612

Family Applications (1)

Application Number Title Priority Date Filing Date
JO200110A JO2334B1 (en) 2000-01-18 2001-01-11 Drospirenone for hormone replacement therapy

Country Status (7)

Country Link
AR (1) AR035633A1 (es)
CO (1) CO5280075A1 (es)
HR (1) HRP20070360B1 (es)
JO (1) JO2334B1 (es)
PE (1) PE20011051A1 (es)
SA (1) SA01210754B1 (es)
UA (2) UA81388C2 (es)

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4426601A1 (de) * 1994-07-27 1996-02-01 Schering Ag Verwendung eines Kombinationsproduktes enthaltend einen kompetitiven Progesteronantagonisten und ein Gestagen zur Herstellung eines Arzneimittels zur Behandlung der Endometriose oder des Leiomyomata uteri
DE19654609A1 (de) * 1996-12-20 1998-06-25 Schering Ag Therapeutische Gestagene zur Behandlung von Premenstrual Dysphoric Disorder
IL148339A0 (en) * 1999-08-31 2002-09-12 Schering Ag Pharmaceutical combination of ethinylestradiol and drospirenone for use as a contraceptive

Also Published As

Publication number Publication date
HRP20070360A2 (en) 2008-12-31
CO5280075A1 (es) 2003-05-30
PE20011051A1 (es) 2001-10-17
SA01210754B1 (ar) 2007-02-17
UA89180C2 (ru) 2010-01-11
UA81388C2 (en) 2008-01-10
HRP20070360B1 (hr) 2014-11-21
AR035633A1 (es) 2004-06-23

Similar Documents

Publication Publication Date Title
YU54602A (sh) Drospirenon za terapiju zamene hormona
MADANES et al. Danazol
NZ516502A (en) Administration of non-oral androgenic steroids to women having an elevated level of sex hormone binding globulin (SHBG)
CA2205897A1 (en) Compositions and methods for contraception and for treatment of benign gynecological disorders
KR20090080989A (ko) 여성 리비도의 유지 및/또는 증가를 위한 경구 치료요법을 위한 디에노게스트와 조합된 에스트라디올 발레레이트 또는 17β-에스트라디올의 용도
EP0799042A1 (de) Progesteronantagonistisch- und antiöstrogen wirksame verbindungen zur gemeinsamen verwendung für die weibliche kontrazeption
US20110009373A1 (en) Composition comprising a combination of an aromatase inhibitor, a progestin and an oestrogen and its use for the treatment of endometriosis
Thorneycroft Update on androgenicity
TR199900764T2 (xx) Bir �strojen bile�i�i ve progestasyonel bir bile�ikten olu�an hormonal bir terkip.
JO2334B1 (en) Drospirenone for hormone replacement therapy
Shulman A review of drospirenone for safety and tolerability and effects on endometrial safety and lipid parameters contrasted with medroxyprogesterone acetate, levonorgestrel, and micronized progesterone
CA2248841C (en) Sequential oestrogen/progesterone antagonist combination for hormone replacement therapy
Whitehead Hormone replacement therapy with estradiol and drospirenone: an overview of the clinical data
HRP20020666A8 (en) Drospirenone for hormone replacement therapy
Schindler Antriandrogen therapy for signs of androgenization: an overview
Schindler COMPOUND CEMICAL STRUCTURE Cimetidine Flutamide
TH134365B (th) โดรสไพริโนนสำหรับการรักษาด้วยการแทนที่ฮอร์โมน
MXPA98007513A (es) Combinacion secuencial de estrogeno/antagonista de progesterona para terapia de reemplazo de hormonas
MXPA01008772A (es) Uso de hormonas sexuales para obtener una composicion farmaceutica nasal que es util en el tratamiento del sangrado uterino indeseable
TH134365A (th) โดรสไพริโนนสำหรับการรักษาด้วยการแทนที่ฮอร์โมน